Clinical trial
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the…
NCT00257660 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00257660 |
|---|---|
| Title | Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia |
| Official title | A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Dystonia |
| Intervention type | Biological, Drug |
| Interventions | Botulinum toxin type A, Placebo |
| Enrollment | 116 |
| Start date | Oct 10, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Nov 23, 2005 |
| Last update posted | Sep 28, 2022 |
| Countries | Russia, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: